| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer
1 company
Santos David A is an EVP, Chief Commercial Officer at RIGEL PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | RIGL Rigel Pharmaceuticals Inc | EVP, Chief Commercial Officer | Sell | 3,921 | $21.38 | $83,836.22 | -3.6% | -20.1% | +45.4% | |
| Feb 5, 2024 | RIGL Rigel Pharmaceuticals Inc | EVP, Chief Commercial Officer | Sell | 14,519 | $1.14 | $16,495.65 | -2.0% | +4.3% | +78.3% | |
| Feb 2, 2023 | RIGL Rigel Pharmaceuticals Inc | EVP, Chief Commercial Officer | Sell | 5,388 | $1.66 | $8,945.16 | -3.6% | -35.0% | -35.6% |